Thats because GLP-1 medicines cause the stomach to empty more slowly, supporting weight loss by making people feel fuller, longer
The effects of delayed gastric emptying may further compound the risk factors harbored by the obese, diabetic patient: Gastroparesis secondary to diabetes-related autonomic dysfunction Bowel dysmotility from opioids (chronic pain) and prolonged bed-rest Altered oesophageal-gastric anatomy from bariatric surgery Gastric insufflation from overzealous bag-valve ventilation with high PEEP and difficult airway Reduced efficacy of routine antiemetic regime Nausea and vomiting are reported by approximately 50% of patients using GLP-1 agonists, as direct results of reduced gastric motility and activation of central satiety centers
If not already doing so, individuals should be prepared to make lifestyle changes, including adopting a reduced-calorie eating pattern and increasing physical activity
According to the company's published pricing, the platform offers compounded semaglutide injections starting at $179 per month, compounded oral GLP-1 tablets starting at $249 per month, and branded Ozempic at $1,999 per month
These insights are critical for safe and effective treatment